获取演示
Now livetag icon
The official Gen AI Landscape report for 2026 is here. Don’t miss out!Get your copybanner icon
ORIC Pharmaceuticals

六月 2026

  • Home
  • ORIC Pharmaceuticals

六月 2026的ORIC Pharmaceuticals市场份额分析

ORIC® is a science-driven, clinical stage company dedicated to developing novel therapies to improve patients’ lives by Overcoming Resistance In Cancer. We offer a collaborative, empowering culture that gives all employees the authority, responsibility and support to do cutting-edge work on advancing therapies for treatment-resistant cancers. Our culture and values support our mission, provide a […]
成立年份2014
员工51 - 200
年营收$25M - $50M
oricpharma.com
ORIC Pharmaceuticals
ORIC Pharmaceuticals(包含公司地区分支机构)
  • oricpharma.com
    oricpharma.com
查看更多网站流量和参与度信息

ORIC Pharmaceuticals收入截至 六月 2026为 25M - 50M

ORIC Pharmaceuticals主要域名产生的收入

3 年中ORIC Pharmaceuticals主要域名的收入

ORIC Pharmaceuticals主要域名的收入


ORIC Pharmaceuticals热门域名的总访问量

了解ORIC Pharmaceuticals市场份额和潜在市场覆盖范围。

过去 3 个月的总访问量

子公司明细

ORIC Pharmaceuticals热门域名的平均访问时长

分析ORIC Pharmaceuticals参与度指标。

过去 3 个月的平均访问时长

子公司明细

ORIC Pharmaceuticals热门域名的平均页面浏览量

了解ORIC Pharmaceuticals如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。

过去 3 个月的平均页面浏览量

子公司明细

想要获取更深入的流量洞见?

过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。



ORIC Pharmaceuticals 采用的主要技术

这些是排名前 ORIC Pharmaceuticals 的顶级域名所使用的网站技术(按行业分列)

小部件 (5)

人才招聘 (3)

WP Job Manager

WP Job Manager

内容管理系统 (2)

WordPress

WordPress

电子邮件服务 (2)

Microsoft Exchange Online

Microsoft Exchange Online

更多技术

7

查看全部

准备好发现优质潜在客户了吗?

借助 Similarweb 销售情报解决方案,确定任意网站使用了哪些技术来设计完美的销售宣传,并缩短销售周期。


ORIC Pharmaceuticals 的新闻与信号

借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。

新闻ORIC Pharmaceuticals, Inc. will attend event European Society for Medical Oncology (ESMO) Congress 2026 on Oct 23rd '26.SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, July 20, 2026 (GLOBE NEWSWIRE) - ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing and commercializing treatments that address mechanisms of therapeutic resistance, today announced three poster presentations at the European Society for Medical Oncology (ESMO) Congress 2026, taking place October 23-27, 2026, in Madrid, Spain.
新闻ORIC Pharmaceuticals, Inc. attended event 2026 American Association for Cancer Research (AACR) Annual Meeting on Apr 17th '26.SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, March 17, 2026 (GLOBE NEWSWIRE) - ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that multiple abstracts highlighting the potential of rinzimetostat (ORIC-944), a potent and selective allosteric inhibitor of PRC2 to treat prostate cancer, have been accepted for poster presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting taking place April 17-22, 2026 in San Diego, CA.
新闻ORIC Pharmaceuticals, Inc. attended event ESMO Asia Congress 2025 on Jul 1st '25.SOUTH SAN FRANCISCO and SAN DIEGO, Dec. 03, 2025 (GLOBE NEWSWIRE) - ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced two late-breaking oral presentations highlighting data from a Phase 1b trial of enozertinib (ORIC-114) at the ESMO Asia Congress 2025 taking place December 5-7, 2025 in Singapore.

查看 ORIC Pharmaceuticals 的所有信号

让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。